Mania: Symptoms, Duration, and When to Seek Urgent Help
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Mania is a clinical mood episode marked by a sustained, unusually elevated, expansive, or irritable mood together with increased energy or goal-directed activity. It can profoundly change judgment, sleep, speech, spending, relationships, and the ability to recognize risk. Some people feel exhilarated and unusually capable; others appear agitated, angry, frightened, or overwhelmed. Recognizing the pattern early matters because a manic episode can escalate into a psychiatric or medical emergency. The National Institute of Mental Health (NIMH) describes mania as a significant change from a person's usual mood, energy, activity, and behavior, rather than a momentary emotional high.
If someone experiencing possible mania is unable to remain safe, has hallucinations or delusions, is severely agitated or confused, is going without essential sleep while becoming increasingly disorganized, is behaving dangerously, or may harm themselves or another person, seek emergency medical evaluation now. In the United States, call 911 for immediate danger; for a suicide or mental health crisis, call or text 988 for crisis support. A shorter symptom duration does not make an escalating situation safe. The NICE bipolar disorder guideline calls for urgent crisis support and risk assessment during acute episodes, and the 988 Suicide & Crisis Lifeline explains its free call, text, and chat services.
For additional clinical context, see Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment, Hypomania: Symptoms, Duration, and Clinical Significance and Mania vs Hypomania: Key Differences in Symptoms and Impairment.
What is mania?
A manic episode is a defined period in which mood and energy become persistently and distinctly different from the person's baseline. In the diagnostic framework commonly used in the United States, the mood change involves elevated, expansive, or irritable mood and abnormally increased activity or energy. It must occur alongside a characteristic cluster of other symptoms, cause marked impairment or require hospitalization, or involve psychotic features. A clinician also investigates whether a substance, medication, or medical illness better explains the presentation. These distinctions are central to the American Psychiatric Association's explanation of bipolar disorders and the World Health Organization's ICD-11 clinical descriptions and diagnostic requirements.
Mania is most closely associated with bipolar I disorder. One lifetime manic episode can establish the manic-episode component of a bipolar I diagnosis when the relevant diagnostic criteria and exclusions are met. Depressive episodes are common in bipolar I disorder but are not required for that diagnosis. Bipolar II disorder involves hypomania and major depression and, by definition, does not include a history of full mania. A person who develops a manic episode requires clinical reassessment even if they were previously diagnosed with bipolar II disorder. See the NIMH overview for the diagnostic distinctions.
The word "manic" is sometimes used casually for enthusiasm, productivity, frequent talking, or rapidly changing interests. These behaviors can occur for many reasons. Clinical mania is recognized through its episode pattern, intensity, observable change, functional effects, and clinical context. Personality, creativity, ordinary happiness, and an isolated impulsive purchase do not establish a manic episode.
What are the main symptoms of mania?
The symptoms usually develop as an interconnected change in mood, thinking, sleep, and behavior. The pattern can look different across individuals and even across episodes in the same person. The descriptions below reflect the symptom domains identified by NIMH, the American Psychiatric Association, and the 2023 VA/DoD bipolar guideline.
Elevated, expansive, or unusually irritable mood
A person may seem euphoric, excessively optimistic, unusually sociable, emotionally intense, or convinced that everything is possible. An expansive mood can involve exaggerated confidence and behavior that crosses customary social boundaries. Other people develop predominantly irritable or angry mania, becoming unusually argumentative or reacting intensely when their plans are questioned. Irritability on its own is nonspecific; clinicians assess it together with increased energy and the other episode features.
Increased energy, agitation, and goal-directed activity
Someone may start numerous projects simultaneously, reorganize their surroundings overnight, contact dozens of people, travel unexpectedly, initiate business ventures, or become intensely involved in social, professional, sexual, or creative activity. Activity may appear purposeful at first but become disorganized as the episode progresses. Some individuals are visibly restless rather than productive. The clinical question is whether the increase is sustained, markedly unusual for that person, and connected to other manic features. The NIMH symptom guide specifically identifies increased activity, energy, and restlessness.
Decreased need for sleep
One of the most informative changes is sleeping substantially less than usual while feeling little need for rest. Someone who ordinarily sleeps seven or eight hours may sleep only two or three hours and insist they are energized. This is different from insomnia, in which a person generally wants to sleep but cannot and often feels tired. Reduced need for sleep is an episode feature; escalating sleep loss can also worsen the episode. Sleep changes deserve prompt attention alongside mood and behavior changes, as emphasized by NIMH and NICE.
Fast, pressured speech and racing thoughts
Speech may become markedly rapid, loud, difficult to interrupt, or unusually abundant. Thoughts can feel as though they are moving faster than the person can express them. Ideas may shift rapidly from one topic to another, with loose or difficult-to-follow connections. A listener may notice the change before the person recognizes it. Clinicians distinguish these episodic changes from a person's normal communication style, lifelong attentional patterns, and the effects of stimulants or substances.
Grandiosity and changes in self-appraisal
Grandiosity can range from unusually inflated confidence to fixed beliefs about exceptional power, identity, wealth, talents, influence, or a special mission. Some people announce unrealistic plans with complete certainty or believe they can succeed without ordinary constraints. If beliefs are clearly detached from reality and maintained despite decisive evidence, a clinician evaluates for psychotic symptoms. The presence of grandiose thoughts alone is not enough to diagnose psychosis; context, conviction, and reality testing matter. See the American Psychiatric Association's clinical overview.
Distractibility and impaired judgment
Attention may be captured by every new sound, message, or idea. The person might have difficulty completing conversations or maintaining a coherent sequence of tasks. Judgment can deteriorate while confidence rises, creating a distinctive and dangerous mismatch between perceived ability and actual risk. Financial losses, unsafe driving, conflict at work, exposure to exploitation, substance use, and unsafe sexual situations can follow. The relevant feature is the change during the episode, not a moral judgment about the person's behavior. NIMH describes unusual risk-taking and difficulty carrying out daily responsibilities during bipolar mood episodes.
Risk-taking, disinhibition, and altered social behavior
A person may spend large sums without a workable plan, gamble, make binding commitments, quit a job abruptly, engage in unsafe driving, approach strangers in unfamiliar ways, or undertake activities with substantial physical or legal risks. Increased sexual interest or impulsive encounters may occur, but neither is required for diagnosis. Family and friends may interpret such behavior as deliberate stubbornness; an acute episode can significantly affect appraisal of consequences. Clinical assessment considers both the person's agency and the state-dependent changes in judgment.
How many symptoms are required for a manic episode?
In DSM-based clinical assessment, an episode includes the characteristic mood-and-energy change plus at least three additional symptom categories; when the mood is only irritable, at least four additional categories are required. The categories include inflated self-esteem or grandiosity, decreased need for sleep, increased talkativeness, racing thoughts or flight of ideas, distractibility, increased goal-directed activity or psychomotor agitation, and excessive involvement in activities with potentially painful consequences. Clinicians establish that these symptoms are prominent, constitute a noticeable change, and occur within the same episode. The American Psychiatric Association provides a patient-facing summary of the manic symptom criteria.
Counting symptoms from an online checklist cannot determine whether an episode meets clinical thresholds. A clinician must establish the timeline, severity, functional impairment, baseline behavior, alternative explanations, and any psychotic features. Someone can require urgent medical care before a formal duration threshold is reached, while another person can endorse several symptoms without meeting the criteria for mania.
How long does mania last?
For a DSM-defined manic episode, the characteristic mood and energy changes generally last at least seven consecutive days, for most of the day nearly every day. An episode can qualify at any duration when hospitalization is necessary because of the severity of the symptoms. Untreated episodes may continue beyond one week, sometimes for weeks or longer; severity and duration vary across people and episodes. NIMH and the American Psychiatric Association explain the seven-day or hospitalization diagnostic threshold.
The seven-day criterion is used to classify a full manic episode, not as an instruction to wait seven days before seeking treatment. If sleep is collapsing, behavior is becoming unsafe, thinking is disorganized, or psychotic symptoms appear after only one or two days, immediate assessment can be necessary. A person who has a known bipolar disorder relapse plan should follow the plan's instructions for contacting their clinical team when early warning signs appear. The NICE guideline recommends individualized crisis planning and timely specialist responses.
A treatment response is also not identical to full recovery. Agitation and sleep may improve before insight, judgment, cognition, relationships, or work functioning return to baseline. Clinical teams monitor residual symptoms, medication effects, and the possibility of a subsequent depressive period. Persistent difficulties after the most visible manic symptoms have settled deserve follow-up rather than an assumption that everything has returned to normal. Long-term management and relapse prevention are core parts of the VA/DoD guideline.
How does mania begin, and can it develop gradually?
Some manic episodes begin with changes that initially seem attractive: fewer hours of sleep, unusual confidence, extra energy, a burst of plans, or intense social activity. Other episodes begin with tension, irritability, pacing, or rapidly escalating arguments. A person or their supporters may notice that several ordinary activities have changed together: messages arrive through the night, purchases multiply, plans become unrealistic, and attempts to discuss consequences are increasingly difficult. NIMH emphasizes changes in mood, behavior, activity, and sleep that are noticeable to others.
An early change is a reason for timely assessment, not proof that a manic episode will inevitably occur. Sleep deprivation, stimulant exposure, medication changes, substance use, acute stressors, and medical illnesses can produce overlapping symptoms and may be relevant triggers in vulnerable individuals. The pattern must be assessed longitudinally. During assessment, an accurate sequence of days, sleep duration, medications, and behavior is more useful than an impression that someone has become "a different person."
Mania versus hypomania
Hypomania and mania share elevated or irritable mood, increased energy, reduced need for sleep, and other symptom categories. Hypomania is diagnostically distinct because it lasts at least four consecutive days in the DSM framework and produces an observable change without the marked functional impairment, psychiatric hospitalization, or psychosis that establishes mania. If psychotic features are present, the episode is classified as manic rather than hypomanic. Both can have serious consequences and warrant professional assessment. The American Psychiatric Association and CANMAT/ISBD 2023 update describe the distinctions.
The difference is more than a numerical severity score. Clinicians consider duration, the extent of disruption, need for hospital care, reality testing, and the course over time. Bipolar II disorder is not simply a "mild" version of bipolar I: its depressive burden and functional consequences can be substantial even though full manic episodes are absent. Hypomania may feel productive and can therefore be underreported, particularly when a person seeks treatment primarily for depression. See the CANMAT/ISBD evidence update.
Can mania include psychosis or mixed symptoms?
Severe mania may include delusions, hallucinations, or markedly disorganized thinking. Delusions may concern extraordinary powers, identity, wealth, personal significance, or perceived threats. Hallucinations can occur, and clinicians examine whether psychotic symptoms are confined to a mood episode or also occur outside episodes. New psychotic symptoms, impaired reality testing, or severe confusion warrant urgent professional evaluation. The VA/DoD clinical guideline covers diagnostic triage and specialty management of acute bipolar presentations.
A manic episode can also have mixed features, meaning that clinically important depressive symptoms occur during a predominantly manic episode. Agitation, despair, racing thoughts, hopelessness, and heightened energy can coexist. These combinations demand careful assessment of suicide risk, treatment phase, and diagnostic criteria. The label "mixed" should be assigned according to diagnostic rules rather than any rapidly alternating feelings. NIMH describes mixed mood presentations, while CANMAT/ISBD addresses their implications for treatment decisions.
When does mania require urgent help?
The need for urgent care depends on danger, degree of behavioral change, medical concerns, and ability to make safe decisions. Clinical severity takes precedence over whether the symptoms have lasted a week or a formal diagnosis has already been established. NICE recommendations specifically address crisis services, risk assessment, calming environments, and precautions during acute mania.
Seek emergency evaluation immediately when safety or basic functioning is at risk
Emergency medical evaluation is appropriate when someone has suicidal intent or an immediate risk of harming another person; experiences hallucinations, fixed delusions, severe confusion, or profoundly disorganized behavior; becomes highly agitated or aggressive; is driving or behaving in a way that creates immediate danger; cannot maintain food, fluids, shelter, or basic medical care; or has severe symptoms requiring possible hospitalization. Sudden psychiatric symptoms accompanied by fever, seizures, loss of consciousness, head injury, severe medical illness, or intoxication also require emergency medical assessment. Medical and psychiatric emergencies can overlap. The NICE bipolar crisis recommendations and the VA/DoD diagnosis-and-triage guideline inform these recommendations.
If you are in the United States and a situation presents immediate danger, call 911 or go to the nearest emergency department. If you or another person is experiencing suicidal thoughts or an emotional crisis, call or text 988 or use the 988 Lifeline's online chat. For readers outside the United States, contact local emergency services or a local crisis line. A crisis line can support a person in distress, but it does not replace emergency medical care when immediate physical safety is threatened.
Arrange same-day or prompt clinical assessment when symptoms are escalating
Even without immediate danger, urgently contact a mental health clinician, psychiatrist, primary care professional, or local crisis service when a person abruptly needs very little sleep while becoming increasingly energized, shows accelerating impulsive behavior, makes major unsafe commitments, or loses the ability to examine consequences. People with a known bipolar diagnosis should contact their treating team promptly about possible early relapse. Rapid clinical contact may allow the care plan to be adjusted before hospitalization becomes necessary. The NICE guideline recommends arrangements for access to treatment and crisis responses.
What to do while arranging help
Keep communication brief, clear, and respectful. Reduce unnecessary stimulation and conflict; prioritize a calm place, fluids, food, and an opportunity to rest. Avoid confrontational arguments about grandiose ideas or demanding that a person acknowledge an illness before care is offered. If it is safe and consensual, postpone major financial, employment, or relationship decisions and offer to contact a clinician together. Avoid alcohol, recreational drugs, or attempts to sedate the person with someone else's medication. The NICE guideline advises calmer surroundings, reduced stimulation, and postponing significant decisions during acute episodes.
If someone may be dangerous, do not try to restrain them alone or place yourself at risk. Follow local emergency instructions, communicate observed behaviors rather than speculative labels, and tell responders about severe sleep reduction, available medication lists, substances, medical symptoms, and any known prior episodes. The priority is safe evaluation, not winning an argument about whether the person has mania.
How is a manic episode diagnosed?
Mania is diagnosed through a clinical assessment and longitudinal history, usually performed by a psychiatrist or another qualified clinician experienced in mood disorders. Clinicians identify a distinct episode, establish the change from baseline, review symptom clusters and duration, and evaluate impairment, psychosis, hospitalization, and other explanatory conditions. They often ask permission to obtain observations from family members or trusted supporters because insight and recall can change during mania. The 2023 VA/DoD bipolar guideline includes a diagnosis-and-triage module, and NIMH emphasizes full clinical evaluation.
Assessment commonly includes a timeline of sleep, energy, activity, mood, speech, spending, work functioning, medical symptoms, substances, and medications. The clinician reviews previous periods of depression or elevated mood, family psychiatric history, treatments and responses, and any prior hospitalizations. The question is whether these observations belong to one coherent mood episode and how the episode compares with the individual's customary behavior over time.
Laboratory tests or physical investigations may be indicated to evaluate possible medical contributors, medication effects, or conditions that mimic psychiatric symptoms. The clinician may assess thyroid function, substance exposure, neurological findings, and general physical health as clinically appropriate. There is no single blood test, brain scan, or online questionnaire that establishes a manic episode. Screening instruments can organize information, but their scores require diagnostic interpretation. See the NIMH assessment overview and the World Health Organization ICD-11 clinical manual.
What else can resemble mania?
Differential diagnosis matters because several conditions can produce increased energy, restlessness, reduced sleep, disinhibition, impulsivity, unusual speech, or extreme behavior. The clinical work is to establish time course, sustained mood-and-energy changes, impairment, medications, health conditions, and the presence or absence of psychosis. NIMH and the VA/DoD guideline specifically emphasize medical and substance-related assessment.
Substance- or medication-induced symptoms can resemble mania, including presentations associated with stimulants, some prescribed medications, intoxication, or withdrawal. Clinicians review timing and dose changes, including antidepressants and corticosteroids, in the context of a complete evaluation. Medical and neurological causes can also be relevant, particularly with a first presentation later in life, atypical symptoms, or prominent confusion.
ADHD may involve talkativeness, distractibility, activity, and impulsivity, but clinicians examine whether these are longstanding traits across settings or a distinct sustained change accompanied by abnormal mood and markedly reduced need for sleep. Anxiety and insomnia can cause restlessness and poor sleep, generally with a different subjective need for rest and mood pattern. Personality-related emotional reactivity, including borderline personality disorder, has its own longitudinal and interpersonal patterns; an episodic manic syndrome is assessed separately. For a focused clinical comparison of obsessions and episodic mood changes, see OCD vs Bipolar Disorder.
Psychotic disorders require particular care in the differential diagnosis. Clinicians investigate whether delusions and hallucinations occur only during mood episodes or also persist independently of them, and whether substance-related, medical, or other psychiatric explanations better fit the course. Depression with agitation and mixed features also requires its own evaluation. A person may have more than one condition, so one diagnosis does not automatically rule out another. The WHO ICD-11 CDDR provides the broader classification framework.
What causes mania, and what can trigger an episode?
Bipolar disorders are associated with multiple biological and environmental influences, including familial and genetic vulnerability, altered regulation of mood and sleep-wake rhythms, life events, and medication or substance-related factors. No single psychological experience or chemical imbalance explains all manic episodes. Family history is a risk factor and does not predetermine an individual's diagnosis. The NIMH bipolar overview describes contributions from genetic, biological, and environmental factors.
Changes in sleep and daily rhythm are clinically important because they can be both early signs and contributors to worsening mood instability. Major disruptions to routines, shift work, travel-related sleep loss, and episodes of prolonged wakefulness deserve attention in someone with established bipolar disorder. Substance use and prescribed medication changes can complicate the picture. Researchers study these mechanisms, but an individual's trigger history must be established from their own longitudinal pattern rather than inferred from population associations. NICE and CANMAT/ISBD incorporate sleep, substance use, and relapse planning into clinical care.
How is acute mania treated?
The treatment of acute mania has its own evidence base. Choices depend on severity, risk, psychotic symptoms, co-occurring conditions, previous response, pregnancy-related considerations, medical status, medication interactions, and individual preferences when shared decision-making is possible. Moderate or severe mania commonly requires urgent specialist assessment, and hospitalization may be necessary when safety or essential functioning cannot be maintained. Evidence-informed care generally uses antimanic medications, with supportive environmental measures and reassessment of contributing substances or medications. The 2023 VA/DoD guideline, NICE recommendations, and CANMAT/ISBD update provide phase-specific treatment guidance.
Antipsychotic medications and mood stabilizers
Several antipsychotic medications have demonstrated efficacy in acute mania, and lithium or valproate-based treatment is also used in appropriate patients. Depending on the situation, a clinician may select one medication or combine an antipsychotic with a mood stabilizer. The 2023 CANMAT/ISBD evidence update lists first-line options for adults with acute mania, including lithium, quetiapine, divalproex, aripiprazole, risperidone, asenapine, and cariprazine, among others. Selections are individualized and reflect more than a ranking of short-term symptom effects. See Keramatian, Chithra, and Yatham (2023).
Evidence synthesis supports the efficacy of multiple pharmacologic options, while reminding clinicians that the results come from selected trial populations and different follow-up periods. A 2025 systematic review and network meta-analysis involving 113 trials evaluated adult acute mania treatments and found differences in efficacy and tolerability. A separate 2022 systematic review and meta-analysis found that, in studied acute-mania populations, adding an antipsychotic to a mood stabilizer generally improved outcomes compared with the respective monotherapies, though combination treatment requires attention to side effects. Trial rankings do not replace guideline-based, patient-specific decisions.
Medication safety, monitoring, and interactions
Lithium has a narrow therapeutic range, so clinicians monitor blood levels and kidney and thyroid function, together with hydration status, interacting medicines, and signs of toxicity. Symptoms such as significant vomiting, diarrhea, severe tremor, unsteady walking, or confusion in a person taking lithium warrant urgent medical advice or emergency assessment, depending on severity. Antipsychotics can cause sedation, movement-related adverse effects, restlessness, and metabolic changes; clinical monitoring may include weight, blood pressure, glucose, and lipids. Valproate/divalproex can cause important adverse effects, including hepatic and blood-related problems, and has substantial reproductive and pregnancy-related risks. Specific precautions and eligibility requirements vary across jurisdictions. These monitoring principles are reflected in NICE, CANMAT/ISBD, and NIMH's medication information.
Lamotrigine has an established role in selected bipolar depressive or maintenance contexts but is not an established acute antimanic treatment. Its use also requires careful titration and attention to potentially serious skin rashes. Antidepressants are not a stand-alone treatment for acute mania and can complicate mood switching in some people with bipolar disorder. A clinician may reassess antidepressant treatment during mania, but patients should not independently start, stop, or alter doses of lithium, antipsychotics, valproate, lamotrigine, or antidepressants. The distinctions across acute mania, bipolar depression, and maintenance treatment are explicit in the CANMAT/ISBD phase-specific recommendations and the NICE guideline.
Electroconvulsive therapy and other urgent interventions
Electroconvulsive therapy (ECT) can be considered by specialists for particular severe or treatment-resistant episodes and when rapid treatment is clinically important. It requires a separate informed evaluation of benefits, anesthesia, memory-related adverse effects, and alternative treatments. ECT is not an ordinary home intervention or a routine response to mild symptoms. Guidelines discuss its role in selected acute presentations, including CANMAT/ISBD and NICE.
Medication and acute stabilization are supported by practical care: a calm environment, adequate nutrition and fluids, monitoring of sleep and activity, avoidance of intoxicants, respectful communication, and clear information for family or supporters. After the crisis, psychotherapy, psychoeducation, family work, and relapse planning can help support recovery and ongoing treatment engagement. The evidence for psychotherapy used alongside medication in maintenance or depression should not be treated as evidence that psychotherapy alone reliably stabilizes severe acute mania. CANMAT/ISBD makes these phase distinctions.
What does hospitalization for mania involve?
Hospitalization may be offered when the person requires intensive assessment, protection from serious harm, treatment of psychosis or dangerous agitation, medical stabilization, or structured support when basic needs cannot be met. Clinicians evaluate the least restrictive safe setting consistent with local law and the person's current circumstances. Treatment may include medical investigations, psychiatric assessment, observation, medication initiation or adjustment, sleep restoration, and planning for follow-up after discharge. Details vary across hospitals and healthcare systems. The NICE crisis recommendations and the VA/DoD bipolar guideline provide clinical frameworks for triage and care.
Hospital care can be frightening or upsetting, particularly when an episode has changed insight or led to involuntary evaluation. Good clinical communication explains what is happening, protects dignity and privacy, considers the person's preferences whenever feasible, and involves trusted supporters with appropriate consent and confidentiality protections. Recovery planning begins before discharge and includes medication review, follow-up appointments, warning signs, and a plan for renewed urgent symptoms.
How can a family member or friend help?
The most useful first step is often to describe concrete observations and seek assessment rather than debating a diagnosis. "You have slept two hours a night, have started several expensive purchases, and seem very different from last week" communicates more clinically useful information than "You are manic." Ask about immediate safety, offer practical assistance in contacting care, and share observations with clinicians through appropriate channels. With consent, support a written relapse or crisis plan that identifies trusted contacts and the person's preferences for care. NICE specifically recommends involving carers appropriately and creating individual care plans.
Supporters may also need help managing their own exhaustion, financial exposure, or fear. Maintaining clear boundaries, declining unsafe activities, and seeking crisis assistance are compatible with compassion. Do not attempt to handle a dangerous episode alone. Following improvement, allow time for discussion of what happened and practical repair without using the acute episode as a permanent definition of the person's identity.
Recovery and prevention after a manic episode
Long-term treatment aims to reduce recurrence, improve functioning, support individual goals, and identify early warning signs promptly. Follow-up may involve a phase-appropriate maintenance medication, psychotherapy or psychoeducation, regular sleep and activity patterns, management of co-occurring conditions, and communication with the care team. The treatment that helped end a manic episode is not automatically the best or only long-term regimen; maintenance evidence, adverse effects, previous patterns, and the person's preferences all matter. Consult the VA/DoD guideline and CANMAT/ISBD update.
A relapse plan can record changes that preceded previous episodes, a person's typical amount of sleep, early shifts in spending or communication, clinician contact details, supportive routines, and what family or friends should do if judgment becomes impaired. The plan should also specify when to seek urgent services. Even people who recover well can experience recurrence; recurrence is a reason to revisit care, not evidence that recovery is impossible.
Does mania look different in adolescents, older adults, and during the perinatal period?
Children and adolescents require developmentally informed assessment. High energy, irritability, sleep changes, and behavioral problems occur in many contexts and cannot be interpreted as mania without a distinct episode and careful differential diagnosis. A qualified pediatric mental health professional considers developmental history, family reports, school patterns, trauma, medications, medical issues, and age-appropriate safety concerns. Adult medication evidence does not automatically apply to younger patients. See NIMH's guide to bipolar disorder in children and teens and the age-specific sections of CANMAT/ISBD.
For an older adult experiencing possible first-onset mania or an unusual new presentation, medical and neurological evaluation is especially important. Polypharmacy, physical illness, cognitive changes, and interactions may alter both diagnosis and treatment risk. The CANMAT/ISBD 2023 update includes recommendations specific to older adults and emphasizes health comorbidities.
Pregnancy and the period after childbirth require urgent attention when severe mood elevation, insomnia, confusion, or psychotic symptoms emerge, especially soon after delivery. Postpartum psychosis and severe perinatal mood episodes can develop rapidly and require emergency specialist assessment. Medication decisions during pregnancy, around conception, and while breastfeeding need individualized review of maternal and infant risks; reproductive risks are particularly important with valproate. Do not independently stop a prescribed treatment during pregnancy or postpartum. The relevant guidance includes NICE's bipolar recommendations, alongside specialized perinatal mental health care.
Common misunderstandings about mania
A manic episode is not defined by happiness. Euphoric experiences can occur, but irritability, distress, insomnia, psychosis, and loss of control are also possible. A person may be productive during the early phase and later experience profound disruption. Whether an episode feels enjoyable is not a reliable measure of clinical severity. The NIMH overview describes the variability of manic presentations.
Mania is not the same as changing one's mood several times in a day. The diagnostic concept refers to a sustained change in mood and energy over a defined period, assessed against usual functioning. Short-lived emotional reactivity, enthusiasm, anxiety, insomnia, ADHD symptoms, substance effects, and many other experiences require their own assessment. A family member's certainty and an online screening result are not substitutes for diagnosis.
A full manic episode does not mean someone must have experienced depression first. Bipolar I disorder can be diagnosed on the basis of a manic episode when all requirements are met, and depression may or may not have occurred. Mania should also not be confused with hypomania: the distinction has direct consequences for diagnosis and urgency of care. The American Psychiatric Association explains these diagnostic differences.
Frequently asked questions
Can mania last only a few hours?
A few hours of elevated mood or intense energy do not meet the usual DSM duration threshold for a full manic episode. However, severely unsafe behavior, acute psychosis, profound confusion, or serious sleep-related deterioration can require immediate care regardless of duration. A clinician may investigate short episodes as part of a broader longitudinal pattern without prematurely assigning a manic-episode diagnosis. See NIMH.
Can a person be manic without feeling happy?
Yes. Manic mood may be predominantly irritable, angry, agitated, or expansive rather than euphoric. The crucial clinical context is a sustained and significant alteration of mood and energy together with additional symptoms and changes in functioning. An irritable presentation has specific symptom-count considerations in DSM-based assessment, as summarized by the American Psychiatric Association.
Does sleeping very little mean someone is manic?
No. Sleep loss can occur with stress, shift work, substance effects, insomnia, medical illness, and other conditions. In mania, a characteristic clue is a markedly decreased perceived need for sleep alongside increased energy and other episodic changes. Severe sleeplessness combined with emerging unsafe behavior warrants urgent medical evaluation. See NIMH.
Can someone recognize their own mania?
Some individuals notice early signs and seek help; others have reduced insight during a severe episode. Insight can change over time, and a previously effective relapse plan may help bridge that gap. Clinicians may use observations from trusted supporters, with appropriate consent, to understand changes in behavior and functioning. NICE supports collaborative care and crisis planning.
Is mania always caused by bipolar disorder?
No. A manic-like syndrome can have other explanations, including substances, prescribed medications, and medical or neurological conditions. The existence of symptoms must therefore lead to appropriate diagnostic assessment before a bipolar disorder diagnosis is established. The VA/DoD guideline addresses diagnostic triage and differential assessment.
Does mania go away without treatment?
The length and course of episodes vary, and some episodes may eventually subside. Waiting for severe symptoms to pass can expose a person to serious consequences, including injury, psychosis, financial harm, or loss of basic functioning. Prompt assessment and evidence-based treatment improve the chances of safer stabilization and recovery. Long-term relapse prevention remains important after acute symptoms improve. See NIMH and the VA/DoD guideline.
Should family members confront someone who denies being manic?
Usually, a calm discussion of specific changes and safety concerns is more constructive than arguing about a diagnostic label. Offer practical help contacting a clinician, limit stimulation, and prioritize safety. If the person is at immediate risk, contact emergency services. These approaches align with the environmental and risk-management recommendations in NICE CG185.
What should I do if mania develops while taking an antidepressant?
Contact the prescribing clinician promptly, particularly if there is escalating energy, reduced sleep, agitation, impulsive behavior, or psychotic symptoms. The clinician should assess whether medication exposure, an underlying bipolar illness, or another condition explains the change and decide what treatment adjustments are appropriate. Do not change medication independently. CANMAT/ISBD discusses treatment-emergent mood switching and phase-specific antidepressant precautions.
Related Articles
References
American Psychiatric Association. (n.d.). What are bipolar disorders? APA patient and family information.
Huang, W., He, S., Liu, M., & Xu, J. (2025). Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: A systematic review and network meta-analysis of randomized controlled trials. Molecular Psychiatry, 30, 838–847. https://doi.org/10.1038/s41380-024-02705-3.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009.
National Institute for Health and Care Excellence. (2014; updated 2025). Bipolar disorder: Assessment and management (CG185). NICE clinical recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. NIMH clinical information.
National Institute of Mental Health. (n.d.). Bipolar disorder in children and teens. NIMH clinical information.
National Institute of Mental Health. (n.d.). Mental health medications. NIMH clinical information.
Suicide & Crisis Lifeline (988). (n.d.). Get help. 988 Lifeline official service information.
Tajika, A., Hori, H., Iga, J., et al. (2022). Mood stabilizers and antipsychotics for acute mania: Systematic review and meta-analysis of augmentation therapy versus monotherapy from the perspective of time to the onset of treatment effects. International Journal of Neuropsychopharmacology, 25(10), 839–852. https://doi.org/10.1093/ijnp/pyac050.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. Official clinical guideline.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO official publication.